Low levels of CD86+ M1 macrophages and high levels of CD206+ M2 macrophages have been associated with an aggressive phenotype in HCC, suggesting that conjoint analysis of CD86 and CD206 expression may provide a prognostic tool for HCC 46. The gene discussed is CD86; the disease is hepatocellular carcinoma.